What is it about?

Delivery of therapeutics into the brain across the Blood-Brain barrier (BBB) is a key challenge for the treatment of brain disorders. The main goal of this research was to find nanoparticles that would be ideal for crossing the BBB, for future therapeutic applications, and would allow tracking their location within the brain, using CT imaging.

Featured Image

Read the Original

This page is a summary of: The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study, Nanomedicine, June 2017, Taylor & Francis,
DOI: 10.2217/nnm-2017-0022.
You can read the full text:

Read

Contributors

The following have contributed to this page